STAT3 and neoplasm: Furthermore, as shown in Fig. 1a, immunization with STAT3-blocked whole-cell hepatoma vaccine resulted in significant antitumor activity in BALB/c mice challenged with H22 tumor cells, showing significantly lower tumor growth rates compared with the other groups (Fig. 1b).